These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 35015903)

  • 21. Algorithm to select optimal systemic anti-psoriatic drugs in relation with patients' Psoriasis Area and Severity Index score for plaque psoriasis.
    Bae SH; Yun SJ; Lee JB; Kim SJ; Won YH; Lee SC
    J Dermatol; 2016 Jun; 43(6):643-9. PubMed ID: 26598783
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Subcutaneous administration of methotrexate with a prefilled autoinjector pen results in a higher relative bioavailability compared with oral administration of methotrexate.
    Pichlmeier U; Heuer KU
    Clin Exp Rheumatol; 2014; 32(4):563-71. PubMed ID: 24983446
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An intensified dosing schedule of subcutaneous methotrexate in patients with moderate to severe plaque-type psoriasis (METOP): a 52 week, multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
    Warren RB; Mrowietz U; von Kiedrowski R; Niesmann J; Wilsmann-Theis D; Ghoreschi K; Zschocke I; Falk TM; Blödorn-Schlicht N; Reich K
    Lancet; 2017 Feb; 389(10068):528-537. PubMed ID: 28012564
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Etanercept and efalizumab for the treatment of psoriasis: a systematic review.
    Woolacott N; Hawkins N; Mason A; Kainth A; Khadjesari Z; Vergel YB; Misso K; Light K; Chalmers R; Sculpher M; Riemsma R
    Health Technol Assess; 2006 Nov; 10(46):1-233, i-iv. PubMed ID: 17083854
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
    Sbidian E; Chaimani A; Garcia-Doval I; Do G; Hua C; Mazaud C; Droitcourt C; Hughes C; Ingram JR; Naldi L; Chosidow O; Le Cleach L
    Cochrane Database Syst Rev; 2017 Dec; 12(12):CD011535. PubMed ID: 29271481
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of psoriasis severity and inflammatory responses under concomitant treatment with methotrexate plus micronutrients for psoriasis vulgaris: a randomized double blind trial.
    Yousefzadeh H; Jabbari Azad F; Banihashemi M; Rastin M; Mahmoudi M
    Acta Dermatovenerol Alp Pannonica Adriat; 2017 Mar; 26(1):3-9. PubMed ID: 28352928
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A randomized, double-blind, placebo-controlled study to evaluate the addition of methotrexate to etanercept in patients with moderate to severe plaque psoriasis.
    Gottlieb AB; Langley RG; Strober BE; Papp KA; Klekotka P; Creamer K; Thompson EH; Hooper M; Kricorian G
    Br J Dermatol; 2012 Sep; 167(3):649-57. PubMed ID: 22533447
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Methotrexate and Rheumatoid Arthritis: Current Evidence Regarding Subcutaneous Versus Oral Routes of Administration.
    Bianchi G; Caporali R; Todoerti M; Mattana P
    Adv Ther; 2016 Mar; 33(3):369-78. PubMed ID: 26846283
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The combination of calcipotriol and methotrexate compared with methotrexate and vehicle in psoriasis: results of a multicentre placebo-controlled randomized trial.
    de Jong EM; Mørk NJ; Seijger MM; De La Brassine M; Lauharanta J; Jansen CT; Guilhou JJ; Guillot B; Ostrojic A; Souteyrand P; Vaillant L; Barnes L; Rogers S; Klaber MR; Van De Kerkhof PC
    Br J Dermatol; 2003 Feb; 148(2):318-25. PubMed ID: 12588386
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A 52-week trial comparing briakinumab with methotrexate in patients with psoriasis.
    Reich K; Langley RG; Papp KA; Ortonne JP; Unnebrink K; Kaul M; Valdes JM
    N Engl J Med; 2011 Oct; 365(17):1586-96. PubMed ID: 22029980
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of oral methotrexate (MTX) monotherapy vs oral MTX plus narrowband ultraviolet light B phototherapy in palmoplantar psoriasis.
    Ara S; Mowla MR; Alam M; Khan I
    Dermatol Ther; 2020 Jul; 33(4):e13486. PubMed ID: 32356586
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Weekly vs. daily administration of oral methotrexate (MTX) for generalized plaque psoriasis: a randomized controlled clinical trial.
    Radmanesh M; Rafiei B; Moosavi ZB; Sina N
    Int J Dermatol; 2011 Oct; 50(10):1291-3. PubMed ID: 21950300
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Successful Psoriasis Treatment Using NB-UVB with Methotrexate: The Vietnamese Experience.
    Van ED; Diem TP; Thi VB; Xuan THT; Tuan KL; Quynh TN; Thu TV; Van TN; Huu SN; Minh PPT; Huu ND; Van TH; Hau KT; Gandolfi M; Satolli F; Feliciani C; Tirant M; Vojvodic A; Lotti T
    Open Access Maced J Med Sci; 2019 Jan; 7(2):253-255. PubMed ID: 30745973
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Head-to-head, randomised, crossover study of oral versus subcutaneous methotrexate in patients with rheumatoid arthritis: drug-exposure limitations of oral methotrexate at doses ≥15 mg may be overcome with subcutaneous administration.
    Schiff MH; Jaffe JS; Freundlich B
    Ann Rheum Dis; 2014 Aug; 73(8):1549-51. PubMed ID: 24728329
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The efficacy of methotrexate plus pioglitazone vs. methotrexate alone in the management of patients with plaque-type psoriasis: a single-blinded randomized controlled trial.
    Lajevardi V; Hallaji Z; Daklan S; Abedini R; Goodarzi A; Abdolreza M
    Int J Dermatol; 2015 Jan; 54(1):95-101. PubMed ID: 25209868
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and safety of mycophenolate mofetil vs. methotrexate for the treatment of chronic plaque psoriasis.
    Akhyani M; Chams-Davatchi C; Hemami MR; Fateh S
    J Eur Acad Dermatol Venereol; 2010 Dec; 24(12):1447-51. PubMed ID: 20384673
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Golimumab, a human anti-tumor necrosis factor alpha monoclonal antibody, injected subcutaneously every four weeks in methotrexate-naive patients with active rheumatoid arthritis: twenty-four-week results of a phase III, multicenter, randomized, double-blind, placebo-controlled study of golimumab before methotrexate as first-line therapy for early-onset rheumatoid arthritis.
    Emery P; Fleischmann RM; Moreland LW; Hsia EC; Strusberg I; Durez P; Nash P; Amante EJ; Churchill M; Park W; Pons-Estel BA; Doyle MK; Visvanathan S; Xu W; Rahman MU
    Arthritis Rheum; 2009 Aug; 60(8):2272-83. PubMed ID: 19644849
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methotrexate vs. fumaric acid esters in moderate-to-severe chronic plaque psoriasis: data registry report on the efficacy under daily life conditions.
    Inzinger M; Weger W; Heschl B; Salmhofer W; Quehenberger F; Wolf P
    J Eur Acad Dermatol Venereol; 2013 Jul; 27(7):861-6. PubMed ID: 22672248
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dose escalation of parenteral methotrexate in active rheumatoid arthritis that has been unresponsive to conventional doses of methotrexate: a randomized, controlled trial.
    Lambert CM; Sandhu S; Lochhead A; Hurst NP; McRorie E; Dhillon V
    Arthritis Rheum; 2004 Feb; 50(2):364-71. PubMed ID: 14872477
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of methotrexate hepatotoxicity in psoriasis patients: a prospective evaluation of four serum fibrosis markers.
    Chládek J; Simková M; Vanecková J; Hroch M; Vávrová J; Hůlek P
    J Eur Acad Dermatol Venereol; 2013 Aug; 27(8):1007-14. PubMed ID: 22882190
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.